Synthesis of Novel 9-Benzyl-3-methylene-1,5-bis(p-toluenesulfonyl)-1,5,9-triazacyclododecane (CADA) Analogs

Loading...
Thumbnail Image

Authors

Anugu, Sreenivasa R.

Issue Date

2009

Type

Dissertation

Language

Keywords

AIDS , antiviral , CADA , CD4 downmodulation , HIV , organic synthesis

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Cyclotriazadisulfonamide (CADA) inhibits the entry of HIV and HHV-7 by specific down-modulation of the CD4 receptor expression on the surface of lymphocytes and monocytes/macrophages. In this work synthesis and biological activities of novel CADA head group analogs SA01, SA02, SA03, SA04, SA06, SA07, SA08, SA40, SA41 with polar and good leaving groups are reported. The structural modifications of CADA were made to increase potency, reduce cytotoxicity, and improve physical properties. IsoCADA (SA05), an isomer of CADA, was synthesized involving cyclization of 1,5,7-triazabicyclo[4.4.0]dec-5- ene (TBD), a guanidinium base, and tested for its antiviral properties. An alternate method for the macrocyclization of disulfonamide using a palladium catalyst has been successfully developed. This new method obviates the necessity of high dilution, slow addition of the reagent and formation of polymer side products which have limited the synthetic utility of the classical Richman-Atkins macrocyclization method.

Description

Citation

Publisher

License

In Copyright(All Rights Reserved)

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN